Bioanalytics in In Vitro and In Vivo Transformation of Biologically Active Compounds for the Needs of Biomedical Diagnostics

Małgorzata Szultka-Młyńska,Katarzyna Pauter,Justyna Walczak-Skierska,Bogusław Buszewski
DOI: https://doi.org/10.1007/978-3-030-63957-0_1-1
2022-01-01
Abstract:Drugs are active substances which trigger various biological reactions. Generally, the medicine is to improve our health condition, but it is not always so. Having used the drug for a long time or in inadequate doses, various undesirable side effects may occur. Additionally, newly produced drugs may be poisonous if we fail to examine their metabolic biotransformation in the living organism. For this reason, drugs are tested using in vivo and in vitro research in order to evaluate their biological activity and toxicity. In vivo tests concern the research on living animals such as rodents or monkeys, while in vitro tests use isolated enzymes within the microsomal fraction, cells, tissues, and whole organs of animals or people (tests with the biological material taken from a patient). Both pharmacological approaches have their pros and cons. In vitro tests are quicker and cheaper than in vivo tests, but they frequently provide different effects, and the results are not always reflected in the process taking place in living organisms. In vivo tests have many opponents defending animal rights and ethics. For this reason in the world of science, new research methods which would allow the simulation of metabolism without using animals or their organs have been looked for.
What problem does this paper attempt to address?